Investing Experience -
Risk Profile -
Followers
0
Following
0
Blog Posts
0
Threads
6,039
Blogs
Threads
Portfolio
Follower
Following
Summary
Total comments
6,039
Past 30 days
0
Past 7 days
0
Today
0
User Comments
Stock
Stock
Stock
2020-08-11 10:28 | Report Abuse
no power liao,all no power
Stock
2020-08-10 23:16 | Report Abuse
iconic got hotel ,hopefully cuti cuti malaysia can boost iconic hotel biz
Stock
2020-08-10 23:02 | Report Abuse
world covid case looks like downtrend
Stock
2020-08-10 19:54 | Report Abuse
looks like covid will end soon, now only buy machine make mask? isit too late? china mask is over supply , they can give u 80%
Stock
2020-08-10 19:51 | Report Abuse
iconic just buy 2machine to make mask, u see china buy many hundred machine to make mask, 2machine cannot make money la
Stock
Stock
2020-08-10 19:42 | Report Abuse
kpj ready to boom, if vacine out, kpj will get it, faster buy
Stock
Stock
2020-08-10 18:58 | Report Abuse
ahwong95 the shareholder sell all the shares to retailer. walao a
then we all be poh kong boss
Stock
2020-08-10 18:25 | Report Abuse
just now all panic sell really amkhan liao
Stock
Stock
2020-08-10 16:34 | Report Abuse
PETALING JAYA: Plans are underway to encourage the wholesale production of face masks, an essential item which almost all of it is still being imported from China now.
Sources told StarBiz this is because face masks are deemed a central tool to win the battle against Covid-19 pandemic and thus the item has to be considered in light of national security interests.
“There are plans for government subsidies or incentives to be given for the setting up of production facilities for face masks. And the plan is for the whole supply chain to be securely located within the country itself, ” a source said.
“Even the raw materials such as elastic bands on the face masks should be sourced from local players. That is why the government is keen on creating incentives for the whole supply chain to be located within the country, ” the source added.
However, from a business standpoint, the manufacturing of face masks has a low entry barrier and carries the risk of a glut in the event the pandemic slows down.
A report by AFP stated that in China, the tens of thousands of mask-making companies that mushroomed following the coronavirus pandemic are now struggling to survive.
This has come about after some 73,000 companies registered as mask makers in the first half of the year – including over 36,000 new companies in April alone – as prices and demand soared, the report indicated.
But the influx of new companies led to a “dilution in quality and a surge in scams”, according to China-based researchers at Daxue Consulting, as firms from carmakers to diaper producers converted their production lines to make masks.
Now the outbreak is largely under control in mainland China, domestic mask demand has dropped dramatically, pushing prices down, AFP reported.
The report also said that some of the companies that piled into the industry are now backing out.
This has not stopped a number of locally listed companies from venturing into face mask production. Their announcements on these ventures has led to a surge in their share prices, amidst the red-hot stock market.
These include SCGM Bhd, Notion VTEC Bhd, Xidelang Holdings Bhd, Ni Hsin Resources Bhd, Caely Holdings Bhd and Pecca Group Bhd. Some of these companies reckon that their high quality masks and personal protective equipment will differentiate their products from others and hence provide them with higher profit margins.
Notably, another challenges facing the industry is the government’s decision to put a cap on the pricing of face masks.
Following a recent government announcement, ceiling prices for face masks will be reduced to RM1.20 from RM1.50 per unit from Aug 15. Wholesale prices would also be reduced from RM1.45 per unit to RM1.15 from the same date.
Stock
Stock
2020-08-10 16:00 | Report Abuse
glove already over supply,u buy land and make more gloves??? wtf@
Stock
Stock
Stock
2020-08-10 15:25 | Report Abuse
looks like glove over supply
Stock
2020-08-10 15:21 | Report Abuse
scary nia friday and mon trading
Stock
Stock
2020-08-10 14:59 | Report Abuse
singapore topglove very stable, only msia ghost make people panic
Stock
Stock
2020-08-10 12:45 | Report Abuse
supeemax result so so nia
Stock
Stock
Stock
Stock
2020-08-10 12:37 | Report Abuse
big shark make weaker seller to sell cheap stock to them, ccb
Stock
2020-08-10 12:29 | Report Abuse
big shark lol today, keep at discount price
Stock
2020-08-10 10:46 | Report Abuse
glove up back up back!!!
Stock
Stock
2020-08-10 07:47 | Report Abuse
us covid 19 is downtrend, better becareful
Stock
2020-08-10 00:16 | Report Abuse
How long is each clinical trial phase?
Phase 1 trials typically last several months, but less than a year. Because these trials test treatments for safety, not for effectiveness, they may only enroll healthy volunteers.
Around 70% of potential new drugs pass Phase 1 and enter Phase 2, which continues to measure safety, while looking at how effective the treatment is, too. Phase 2 trials recruit up to several hundred patients with the condition to take part. This phase typically lasts several months to two years
Just 33% of drugs make it past Phase 2 and into Phase 3, which tests the potential treatment in the largest number of people. This phase measures both safety and effectiveness with many volunteers, sometimes thousands. Phase 3 trials last from one to three years.
After Phase 3, a pharmaceutical company may submit a New Drug Application (NDA) for the treatment to the Food and Drug Administration (FDA). The FDA then reviews results from all stages of the trial to determine whether it will approve the drug and allow the pharmaceutical company to begin marketing it to the public.
Following approval, a treatment may enter Phase 4, also known as a post-marketing trial. Patients are monitored for long-term side effects of the treatment that go beyond the time frame of the other phases.
Stock
2020-08-10 00:15 | Report Abuse
How long is each clinical trial phase?
Phase 1 trials typically last several months, but less than a year. Because these trials test treatments for safety, not for effectiveness, they may only enroll healthy volunteers.
Around 70% of potential new drugs pass Phase 1 and enter Phase 2, which continues to measure safety, while looking at how effective the treatment is, too. Phase 2 trials recruit up to several hundred patients with the condition to take part. This phase typically lasts several months to two years
Just 33% of drugs make it past Phase 2 and into Phase 3, which tests the potential treatment in the largest number of people. This phase measures both safety and effectiveness with many volunteers, sometimes thousands. Phase 3 trials last from one to three years.
After Phase 3, a pharmaceutical company may submit a New Drug Application (NDA) for the treatment to the Food and Drug Administration (FDA). The FDA then reviews results from all stages of the trial to determine whether it will approve the drug and allow the pharmaceutical company to begin marketing it to the public.
Following approval, a treatment may enter Phase 4, also known as a post-marketing trial. Patients are monitored for long-term side effects of the treatment that go beyond the time frame of the other phases.
Stock
2020-08-10 00:15 | Report Abuse
How long is each clinical trial phase?
Phase 1 trials typically last several months, but less than a year. Because these trials test treatments for safety, not for effectiveness, they may only enroll healthy volunteers.
Around 70% of potential new drugs pass Phase 1 and enter Phase 2, which continues to measure safety, while looking at how effective the treatment is, too. Phase 2 trials recruit up to several hundred patients with the condition to take part. This phase typically lasts several months to two years
Just 33% of drugs make it past Phase 2 and into Phase 3, which tests the potential treatment in the largest number of people. This phase measures both safety and effectiveness with many volunteers, sometimes thousands. Phase 3 trials last from one to three years.
After Phase 3, a pharmaceutical company may submit a New Drug Application (NDA) for the treatment to the Food and Drug Administration (FDA). The FDA then reviews results from all stages of the trial to determine whether it will approve the drug and allow the pharmaceutical company to begin marketing it to the public.
Following approval, a treatment may enter Phase 4, also known as a post-marketing trial. Patients are monitored for long-term side effects of the treatment that go beyond the time frame of the other phases.
Stock
2020-08-10 00:15 | Report Abuse
How long is each clinical trial phase?
Phase 1 trials typically last several months, but less than a year. Because these trials test treatments for safety, not for effectiveness, they may only enroll healthy volunteers.
Around 70% of potential new drugs pass Phase 1 and enter Phase 2, which continues to measure safety, while looking at how effective the treatment is, too. Phase 2 trials recruit up to several hundred patients with the condition to take part. This phase typically lasts several months to two years
Just 33% of drugs make it past Phase 2 and into Phase 3, which tests the potential treatment in the largest number of people. This phase measures both safety and effectiveness with many volunteers, sometimes thousands. Phase 3 trials last from one to three years.
After Phase 3, a pharmaceutical company may submit a New Drug Application (NDA) for the treatment to the Food and Drug Administration (FDA). The FDA then reviews results from all stages of the trial to determine whether it will approve the drug and allow the pharmaceutical company to begin marketing it to the public.
Following approval, a treatment may enter Phase 4, also known as a post-marketing trial. Patients are monitored for long-term side effects of the treatment that go beyond the time frame of the other phases.
Stock
2020-08-10 00:14 | Report Abuse
1 vaccine need 6-10 years, many ppl will keong gan liao
Stock
2020-08-10 00:13 | Report Abuse
How long is each clinical trial phase?
Phase 1 trials typically last several months, but less than a year. Because these trials test treatments for safety, not for effectiveness, they may only enroll healthy volunteers.
Around 70% of potential new drugs pass Phase 1 and enter Phase 2, which continues to measure safety, while looking at how effective the treatment is, too. Phase 2 trials recruit up to several hundred patients with the condition to take part. This phase typically lasts several months to two years
Just 33% of drugs make it past Phase 2 and into Phase 3, which tests the potential treatment in the largest number of people. This phase measures both safety and effectiveness with many volunteers, sometimes thousands. Phase 3 trials last from one to three years.
After Phase 3, a pharmaceutical company may submit a New Drug Application (NDA) for the treatment to the Food and Drug Administration (FDA). The FDA then reviews results from all stages of the trial to determine whether it will approve the drug and allow the pharmaceutical company to begin marketing it to the public.
Following approval, a treatment may enter Phase 4, also known as a post-marketing trial. Patients are monitored for long-term side effects of the treatment that go beyond the time frame of the other phases.
Stock
2020-08-10 00:12 | Report Abuse
clinical trial phases take six to seven years ,
Stock
Stock
2020-08-09 23:51 | Report Abuse
phase 3 vaccine lai liao , keong gan liao
Stock
Stock
2020-08-09 23:49 | Report Abuse
vaccine 3 start liao, keong gan liao
Stock
Stock
Stock
Stock
Stock
Stock
Stock: [POHKONG]: POH KONG HOLDINGS BHD
2020-08-11 14:17 | Report Abuse
cut loss, gold price drop lo